CA1336073C - Traitement des tumeurs malignes a l'aide de 8-aminoadenosine - 3', 5' - phosphate cyclique et son mode de preparation - Google Patents

Traitement des tumeurs malignes a l'aide de 8-aminoadenosine - 3', 5' - phosphate cyclique et son mode de preparation

Info

Publication number
CA1336073C
CA1336073C CA000616661A CA616661A CA1336073C CA 1336073 C CA1336073 C CA 1336073C CA 000616661 A CA000616661 A CA 000616661A CA 616661 A CA616661 A CA 616661A CA 1336073 C CA1336073 C CA 1336073C
Authority
CA
Canada
Prior art keywords
cyclic phosphate
day
tumor
aminoadenosine
chloroadenosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000616661A
Other languages
English (en)
Inventor
Roland K. Robins
Ganapathi R. Revankar
Yu-An Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NUCLEIC ACID RESEARCH INSTITUTE AN ICN PHARMACEUTICALS Inc AND EASTMAN KODAK Co PARTNERSHIP
Original Assignee
NUCLEIC ACID RESEARCH INSTITUTE AN ICN PHARMACEUTICALS Inc AND EASTMAN KODAK Co PARTNERSHIP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/136,407 external-priority patent/US4861873A/en
Priority claimed from CA000564584A external-priority patent/CA1326849C/fr
Application filed by NUCLEIC ACID RESEARCH INSTITUTE AN ICN PHARMACEUTICALS Inc AND EASTMAN KODAK Co PARTNERSHIP filed Critical NUCLEIC ACID RESEARCH INSTITUTE AN ICN PHARMACEUTICALS Inc AND EASTMAN KODAK Co PARTNERSHIP
Priority to CA000616661A priority Critical patent/CA1336073C/fr
Application granted granted Critical
Publication of CA1336073C publication Critical patent/CA1336073C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000616661A 1987-12-21 1993-06-16 Traitement des tumeurs malignes a l'aide de 8-aminoadenosine - 3', 5' - phosphate cyclique et son mode de preparation Expired - Fee Related CA1336073C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000616661A CA1336073C (fr) 1987-12-21 1993-06-16 Traitement des tumeurs malignes a l'aide de 8-aminoadenosine - 3', 5' - phosphate cyclique et son mode de preparation

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/136,407 US4861873A (en) 1987-12-21 1987-12-21 8-Chloroadenosine 3', 5'-cyclic monophosphate preparations
US136,407 1987-12-21
US18007088A 1988-04-11 1988-04-11
US180,070 1988-04-11
CA000564584A CA1326849C (fr) 1987-12-21 1988-04-20 Traitement de tumeurs malignes a l'aide de 8-chloroadenosine-3', 5'-cyclophosphate, et sa preparation
CA000616661A CA1336073C (fr) 1987-12-21 1993-06-16 Traitement des tumeurs malignes a l'aide de 8-aminoadenosine - 3', 5' - phosphate cyclique et son mode de preparation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000564584A Division CA1326849C (fr) 1987-12-21 1988-04-20 Traitement de tumeurs malignes a l'aide de 8-chloroadenosine-3', 5'-cyclophosphate, et sa preparation

Publications (1)

Publication Number Publication Date
CA1336073C true CA1336073C (fr) 1995-06-27

Family

ID=27167930

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000616661A Expired - Fee Related CA1336073C (fr) 1987-12-21 1993-06-16 Traitement des tumeurs malignes a l'aide de 8-aminoadenosine - 3', 5' - phosphate cyclique et son mode de preparation

Country Status (1)

Country Link
CA (1) CA1336073C (fr)

Similar Documents

Publication Publication Date Title
DE69822482T2 (de) Salze von di(uridine 5'-tetraphosphate), verfahren zur herstellung und verwendungen davon
MXPA97002932A (en) L-ribofuranosilnucleosi
CZ242893A3 (en) Antiviral mixtures
JPH06508846A (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤毒性の治療
JPH04505932A (ja) 三つの新規非ポリグルタマートのデアザアミノプテリンと合成方法
US7091334B2 (en) Method for large-scale production of di(uridine 5′)-tetraphosphate and salts thereof
WO2000004866A9 (fr) Elaboration de composes de thioarabinofuranosyl et leurs applications
RU2194511C2 (ru) Применение 5-этинилурацила в качестве инактиватора урацилредуктазы, фармацевтическая композиция, способ ее получения, фармацевтическая композиция для усиления действия или снижения токсичности 5-фторурацила
WO2003053989A1 (fr) Derives nucleosides contenant un phosphate masque, et leur utilisation comme agents antiviraux
EP0788495A2 (fr) Nucleosides l-erythrosyle
US4507301A (en) Anti-cancer composition for delivering 5-fluorouracil
US5041542A (en) Substituted pyrimido[5,4-d]pyrimidine nucleosides
US4861873A (en) 8-Chloroadenosine 3', 5'-cyclic monophosphate preparations
CA1336073C (fr) Traitement des tumeurs malignes a l'aide de 8-aminoadenosine - 3', 5' - phosphate cyclique et son mode de preparation
WO1989005817A1 (fr) Purines antitumorales de 6-sulfenamide, 6-sulfinamide et 6-sulfonamide, nucleosides de purine, nucleotides de purine et composes apparentes
CA1326849C (fr) Traitement de tumeurs malignes a l'aide de 8-chloroadenosine-3', 5'-cyclophosphate, et sa preparation
CN100381459C (zh) 阿霉素的衍生物及其制备方法和用途
CN102250179A (zh) 稳定的蛋白激酶激活剂及其制备方法和用途
RU2418795C2 (ru) Производные диоксолана для лечения рака
US4925930A (en) Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates
IE902656A1 (en) Salts of n5,n10-methylene-5,6,7,8-tetrahydrofolic acid
US5885972A (en) L-pyranosyl nucleosides
JPH0692986A (ja) 置換ヌクレオシド誘導体、その製造法およびそれを含む医薬組成物
MXPA97002927A (es) L-piranosilnucleosidos
US5026836A (en) 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides, pharmaceutical compositions, and processes of making

Legal Events

Date Code Title Description
MKLA Lapsed